GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SSB · Sep 30, 2025

SouthState Bank Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001104659-25-104685Bank
Sequential deposit growth50thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

0.70% · CORE · VALID

Net-income growth84thOwn-history percentile · N=19
Evidence method

Yoy · gp.fundamentals.net_income

72.26% · CORE · VALID

Interest-income growth85thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

62.02% · CORE · VALID

Cash and equivalents50thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$3.1B · CORE · VALID

Sequential loan growth45thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

0.93% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History27 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
0.67%
Current
0.70%
Delta
0.03%
Earnings Growth Increased
Previous
62.59%
Current
72.26%
Delta
9.67%
Interest Income Growth Increased
Previous
58.25%
Current
62.02%
Delta
3.77%
Liquidity Decreased
Previous
$3.5B
Current
$3.1B
Delta
-$319.7M
Loan Growth Decreased
Previous
1.09%
Current
0.93%
Delta
-0.17%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.